Drug Development for Neglected Diseases
From PHM Oz
(Difference between revisions)
DavidLegge (Talk | contribs) |
DavidLegge (Talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
| − | |||
Drugs for Neglected Diseases Initiative (DNDI)[[http://www.dndi.org/]] | Drugs for Neglected Diseases Initiative (DNDI)[[http://www.dndi.org/]] | ||
| − | + | WHO Commission on Intellectual Property Rights, Innovation and Public Health (2.73mb)[[http://www.who.int/intellectualproperty/report/en/]] | |
| − | + | ||
| − | WHO Commission on Intellectual Property Rights, Innovation and Public Health [[http://www.who.int/intellectualproperty/report/en/]] | + | |
Medical Innovation Prize Fund Proposal (James Love)[[http://www.cptech.org/ip/health/prizefund/]] | Medical Innovation Prize Fund Proposal (James Love)[[http://www.cptech.org/ip/health/prizefund/]] | ||
[[Intellectual Property and Pharmaceuticals|Back to IP home]] | [[Intellectual Property and Pharmaceuticals|Back to IP home]] | ||
Revision as of 03:48, 9 July 2007
Drugs for Neglected Diseases Initiative (DNDI)[[1]]
WHO Commission on Intellectual Property Rights, Innovation and Public Health (2.73mb)[[2]]
Medical Innovation Prize Fund Proposal (James Love)[[3]]
